0000-00-00 |
|
|
|
External link to document |
2022-01-07 |
100 |
Notice of Service |
Stephenson, Ph.D. Regarding Invalidity of U.S. Patent No. 10,457,666 and (2) Second Reply Expert Report of Nicholas…30 December 2019
1:19-cv-02368
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |
2024-02-09 |
199 |
Stipulation-General (See Motion List for Stipulation to Extend Time) |
STIPULATION and Covenant Not to Sue regarding U.S. Patent No.10,457,666 by Taiho Oncology, Inc., Taiho Pharmaceutical…30 December 2019
1:19-cv-02368
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |
2024-02-09 |
200 |
SO ORDERED |
Stipulation and Covenant Not to Sue regarding U.S. Patent No.10,457,666. Signed by Judge Jennifer L. Hall on 2/9…30 December 2019
1:19-cv-02368
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |
2019-12-30 |
4 |
Patent/Trademark Report to Commissioner of Patents |
Commissioner of Patents and Trademarks for Patent/Trademark Number(s) RE46,284 E ;9,527,833 C1 ;10,457,666 B2. (…30 December 2019
1:19-cv-02368
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |
2021-07-22 |
64 |
|
.D. Regarding Invalidity of U.S. Patent Nos. 9,527,833 and 10,457,666 and (2) Expert Report of Nicholas…30 December 2019
1:19-cv-02368
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |
2021-07-22 |
65 |
|
, M.D. Concerning the Invalidity of U.S. Patent No. RE46,284 filed by Natco Pharma Ltd., Natco Pharma,…30 December 2019
1:19-cv-02368
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |